S&P 100
2.762,36
PKT
+43,17
PKT
+1,59
%
Werbung
Analysen zu S&P 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.04.12 | AT&T equal-weight | Barclays Capital | |
11.04.12 | Cisco overweight | JP Morgan Chase & Co. | |
11.04.12 | Intel buy | Caris & Company, Inc. | |
10.04.12 | QUALCOMM outperform | Oppenheimer & Co. Inc. | |
10.04.12 | QUALCOMM buy | UBS AG | |
10.04.12 | Citigroup overweight | Barclays Capital | |
10.04.12 | ConocoPhillips sell | UBS AG | |
10.04.12 | Cisco buy | Nomura | |
10.04.12 | JPMorgan Chase overweight | Barclays Capital | |
10.04.12 | Capital One Financial overweight | Barclays Capital | |
10.04.12 | QUALCOMM overweight | Barclays Capital | |
10.04.12 | QUALCOMM outperform | Sanford C. Bernstein and Co., Inc. | |
10.04.12 | Microsoft hold | Needham & Company, LLC | |
10.04.12 | MasterCard buy | Stifel, Nicolaus & Co., Inc. | |
05.04.12 | Apple overweight | Piper Jaffray & Co. | |
05.04.12 | McDonalds buy | Goldman Sachs Group Inc. | |
05.04.12 | Visa outperform | Oppenheimer & Co. Inc. | |
05.04.12 | MasterCard outperform | Oppenheimer & Co. Inc. | |
05.04.12 | IBM neutral | Banc of America Securities-Merrill Lynch | |
05.04.12 | Devon Energy buy | UBS AG | |
05.04.12 | Chevron neutral | Sarasin Research | |
05.04.12 | Starbucks buy | Goldman Sachs Group Inc. | |
05.04.12 | Apple overweight | Barclays Capital | |
05.04.12 | ExxonMobil outperform | Macquarie Research | |
05.04.12 | Biogen buy | Goldman Sachs Group Inc. | |
04.04.12 | Citigroup buy | Nomura | |
04.04.12 | Oracle hold | Deutsche Bank Securities | |
04.04.12 | Bank of America neutral | Nomura | |
04.04.12 | Linde neutral | HSBC | |
04.04.12 | Philip Morris neutral | Credit Suisse Group | |
04.04.12 | Pfizer halten | Independent Research GmbH | |
04.04.12 | Netflix equal-weight | Barclays Capital | |
03.04.12 | Coca-Cola hold | Stifel, Nicolaus & Co., Inc. | |
03.04.12 | Linde neutral | Nomura | |
03.04.12 | Bank of America hold | Deutsche Bank Securities | |
03.04.12 | Microsoft buy | UBS AG | |
03.04.12 | Intel outperform | Credit Suisse Group | |
03.04.12 | Linde buy | Sarasin Research | |
03.04.12 | Amgen outperform | RBC Capital Markets | |
03.04.12 | Citigroup buy | Deutsche Bank Securities |